Compare Eden and Hims & Hers for GLP-1 care. Explore how personalization, licensed provider access, and pharmacy coordination differ.
Interest in GLP-1 medications continues to grow as more individuals explore medical options to support their metabolic health. Wegovy® and Ozempic® are different formulations of semaglutide, each approved by the FDA for distinct uses. Wegovy is approved for chronic weight management in adults with obesity or overweight with related conditions. In contrast, Ozempic is approved for the treatment of type 2 diabetes and is not indicated for weight loss.
As demand grows, patients are turning to digital health platforms to explore treatment options and connect with licensed providers. Two of the most recognizable platforms, Eden and Hims & Hers, both offer access to GLP-1 medications, but they operate with very different care models.
This article breaks down how each platform works, what kind of patient experience they offer, and how Eden’s personalized and lab-informed model compares with Hims & Hers’ broader but more standardized approach.
Eden is a digital health platform focused on helping individuals improve their metabolic health. Eden does not manufacture or dispense medications, nor does it provide medical services directly. Instead, Eden connects patients with independent licensed healthcare providers who evaluate whether a patient may be a good candidate for GLP-1 medications based on their health profile.
If a provider determines that treatment is appropriate, prescriptions may be filled by state-licensed compounding pharmacies.
Key components of Eden’s approach:
Looking for care designed around your needs? Eden helps you connect with licensed providers who can guide your next steps with a personalized approach.
Speak with a provider about your treatment options →
Hims & Hers is a well-established telehealth platform offering access to providers for a wide range of concerns, such as hair loss, sexual health, anxiety, and dermatology. The company has also expanded into GLP-1 medications and metabolic support.
Hims & Hers’ model typically includes:
While Hims & Hers offers a broad range of services, its care model is generally designed for efficiency and accessibility, with less emphasis on personalized treatment planning.
{{primary-cta}}
Eden begins the care journey with lab testing, allowing providers to base treatment recommendations on actual biomarker data. This enables a more customized approach and supports a safer, more effective treatment journey. Patients with certain metabolic markers, such as insulin resistance, may benefit from a provider’s ability to tailor dosing or select appropriate adjunct therapies.
A 2024 peer-reviewed study published in Frontiers in Endocrinology supports this approach, suggesting that GLP-1 medications may be more effective when guided by baseline metabolic status.
Benefits of Eden’s approach:
Want a care experience built around your goals? Take the first step with Eden and connect with a provider who understands your needs.
In contrast, Hims & Hers focuses on simplicity and ease of access. Users complete a brief intake form, which is reviewed by a provider before medication is prescribed. While this can be efficient, it may not provide the same degree of precision for individuals with more complex or evolving metabolic needs.
After initial consultation and lab review, Eden users maintain contact with their provider through scheduled follow-ups, ensuring ongoing optimization and oversight. This may allow for:
This continuity supports adherence and outcomes, especially during GLP-1 initiation when side effects such as nausea or fatigue may be common. As noted in an AJCN study, patient-provider collaboration is essential during dose escalation phases.
While Hims & Hers does offer follow-ups, they are often limited to message-based communication. This may be sufficient for users who want a lower-engagement model, but it might not meet the needs of patients requiring nuanced support during treatment adjustments.
Eden partners with state-licensed compounding pharmacies to fulfill prescriptions written by providers on its platform. These pharmacies prepare medications in accordance with legal and clinical standards. Eden does not compound, own, or ship medication itself.
Eden ensures:
Hims & Hers partners with pharmacies to fulfill both commercial and compounded prescriptions. However, the platform may provide limited transparency into how compounded medications are prepared or tailored to individual treatment plans, compared to models that emphasize provider-guided customization.
{{primary-cta}}
GLP-1 medications are most effective when paired with behavior change, according to a 2024 study. Eden includes wellness resources and provider support designed to encourage long-term success.
Support tools may include:
Hims & Hers may offer some content-based resources, but users may not receive the same level of personalized support or proactive follow-up.
When choosing between Eden and Hims & Hers for GLP-1 care, the best option depends on your goals:
Whatever you choose, the most important step is to talk with a licensed healthcare provider who can evaluate your eligibility and guide you through safe, effective options.
Ready to get started? Take the first step toward a care plan built around your health goals.
This blog is for informational purposes only and does not constitute medical advice. Eden is not a pharmacy and does not practice medicine. Eden connects individuals with licensed healthcare providers who may prescribe medications when appropriate. GLP-1 medications such as semaglutide are not FDA-approved for weight loss unless indicated under specific brands like Wegovy. Always consult a licensed provider before beginning any medical treatment.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
